相关实验视频
Updated: May 22, 2025

10:35
Stereotactic Radiosurgery for Gynecologic Cancer
Published on: April 17, 2012
17.7K
辅助化疗与单独放射治疗对于患有中等风险宫癌的患者
Núria Agustí1, David Viveros-Carreño2,3, Chi-Fang Wu1
1The University of Texas MD Anderson Cancer Center, Houston.
JAMA oncology
|March 13, 2025
概括
添加化疗和放射治疗并没有改善中等风险宫癌患者的整体存活率. 这项研究发现,在接受化疗和仅接受放射治疗的患者中,没有显著的生存益处.
科学领域:
- 妇科瘤学 妇科瘤学
- 辐射瘤学 辐射瘤学
- 临床试验分析
背景情况:
- 对中等风险宫癌的最佳辅助治疗进行了讨论.
- 在这个患者群体中,结合化疗和放射治疗的益处尚不清楚.
- 目前的治疗策略需要进一步基于证据的评估.
研究的目的:
- 为了确定辅助化疗或放射治疗是否改善了与单独放射治疗相比的整体存活率,在中等风险的宫癌中.
- 为了确定与这种人群中使用化疗放射治疗相关的临床因素.
主要方法:
- 一项基于美国的队列研究利用了国家癌症数据库数据 (2010-2020年).
- 包括的患者患有IB阶段的宫癌,中等风险的激进子宫切除术后.
- 倾向性得分匹配 (1:1) 和卡普兰-梅尔分析比较了单独放射治疗和化疗放射治疗组之间的生存率.
主要成果:
- 分析了1116名患者;486人接受了化疗或放射治疗.
- 化学辐射疗法在腺癌/腺状组织学和较大的瘤 (>4厘米) 中更频繁.
- 总体存活率相似:5年存活率为化学放射治疗和单独放射治疗组的87% (HR,0.85;P=.38).
结论:
- 辅助化疗和放射治疗似乎没有改善中等风险宫癌患者的整体存活率.
- 根据瘤特征或治疗方式,在子组之间没有观察到显著的生存差异.
- 研究结果表明,单独的放射治疗可能足以治疗这种患者队列.
更多相关视频
09:48An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
8.0K
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.4K
相关概念视频
Comparing the Survival Analysis of Two or More Groups
113
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
113
Cancer Survival Analysis
315
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
315
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K